Anthropometric measurements and survival after a prostate cancer diagnosis

Background: Evidence regarding the role of anthropometrics in prostate cancer survival is inconsistent. We examined the associations between anthropometric measures and survival outcomes. Methods: Men diagnosed with prostate cancer ( n =987) were recruited into a population-based case–control study...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2018-02, Vol.118 (4), p.607-610
Main Authors: Farris, Megan S, Courneya, Kerry S, Kopciuk, Karen A, McGregor, S Elizabeth, Friedenreich, Christine M
Format: Article
Language:English
Subjects:
692/699/67/589/466
692/700/139
692/700/1421
692/700/1750
Anthropometry
Biomedical and Life Sciences
Biomedicine
Body composition
Body mass
Body Mass Index
Body measurements
Body Weight
Cancer Research
Case-Control Studies
Diagnosis
Drug Resistance
Epidemiology
Health risk assessment
Hip
Humans
Male
Medical diagnosis
Molecular Medicine
Mortality
Oncology
Population studies
Prognosis
Prospective Studies
Prostate cancer
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - mortality
Survival
Survival Analysis
Waist Circumference
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Evidence regarding the role of anthropometrics in prostate cancer survival is inconsistent. We examined the associations between anthropometric measures and survival outcomes. Methods: Men diagnosed with prostate cancer ( n =987) were recruited into a population-based case–control study between 1997 and 2000 then a prospective cohort study between 2000 and 2002 where anthropometric measurements (weight, height, body mass index, waist circumference, waist-hip ratio) were taken and participants were followed up to 19 years for survival outcomes. Cox proportional hazards were used to examine these associations. Results: Survival analyses suggested no clear pattern of associations between post-diagnosis anthropometric measurements and all-cause mortality, prostate-specific mortality, first recurrence/progression or new primary cancer. Conclusions: We did not find a significant trend relating anthropometrics to survival outcomes after prostate cancer diagnosis. Continued assessment of objective measurements of body composition over the life-course is warranted to determine true associations between anthropometrics and survival after prostate cancer.
ISSN:0007-0920
1532-1827
DOI:10.1038/bjc.2017.440